Medical knowledge | Infectology » Infection Prevention Leadership Summit, Speaker Biographies

Source: http://www.doksinet Infection Prevention Leadership Summit – Speaker Biographies From September 27-28, 2010, 3M will gather infection prevention professionals from around the country to learn about trends in infection prevention and new ways to eliminate HAIs through knowledge, collaboration and leadership. Keynote address from Dr Warren, Dr Lloyd and Julie Kliger will be Webcast live and archived for one hour of Sterile Processing or RN CE credit per each session. For links to these programs, please visit: www3mcom/LeadershipSummit/ConnectWithUS The summit will feature preeminent thought leaders in infection prevention practices, including: Lisa Brosseau, ScD, CIH, University of Minnesota School of Public Health Topic: What Role Should Respiratory Protection Play in the Prevention of AerosolTransmissible Disease? Dr. Brosseau has been a faculty member in the University of Minnesotas School of Public Health since 1991. Her research and publications focus on the performance

of respiratory protection, measurement of aerosols, assessment of workplace exposures to hazardous materials and wastes, and provision of environmental, health and safety assistance to small businesses. Dr. Brosseau was Chair of the American Conference of Industrial Hygienists (ACGIH) Threshold Limit Values for Chemical Substances Committee from 1995-2005 and is currently Vice Chair Elect of ACGIH. She has participated in national and international policy efforts concerned with respirator use for control of exposures to airborne infectious aerosols. She received her Masters and Doctoral degrees in industrial hygiene from the Harvard School of Public Health. Mark Duro, CRCST, manager, New England Baptist Hospital Central Sterile Processing department Topic: We Are All In This Together - What Do You Expect of Your CSSD? Mark Duro is the manager of the New England Baptist Hospital Central Sterile Processing department, a leading hospital in orthopedics and the official hospital of the

Boston Celtics. Duro has been in the sterile processing management profession for the past twenty years and is the current Vice President of the Massachusetts Chapter of Central Services professionals. He has been a member of IAHCSMM since 1992, is the current chair of IAHCSMM’s Orthopedic Council and is also an IAHCSMM-approved instructor. Additionally, Duro serves on the AAMI ST79 working group Richard Evans, MD, director of the Center for Hip and Knee Surgery and chief of Adult Reconstruction Topic: Reduction in the Perioperative Setting Dr. Evans is a hip and knee replacement specialist and in addition to performing surgery, Dr Evans is an associate professor in the College of Medicines Department of Orthopaedic Surgery. Previously, he was professor of Clinical Orthopedic Surgery at the University of Missouri Health Sciences Center. Prior to that, he had been in private practice in Denver where he was president and CEO of Cherry Creek Orthopedic Specialists from 1989-2005 and was

assistant clinical professor at the University of Colorado Health Sciences Center. Dr. Evans graduated from the University of Colorado School of Medicine in Denver, and served a 1983-1984 transitional surgery internship at Presbyterian/St. Lukes Medical Center in Denver His time at UAMS included a research fellowship under Dr. Nelson at the Center for Musculoskeletal Research in 1984-1985. He completed his residency at UAMS in 1989, and was winner of the Outstanding Orthopedic Resident-Teacher Award. He was named Orthopedic Surgeon of the Year 2001 by the editorial staff of Consumer Business Review in Denver, and has been a five-time winner of the Presbyterian/St. Lukes Medical Center Rehabilitation Top Doc award Source: http://www.doksinet Dr. Evans is the chairman-elect of the Patient Safety Committee of the American Academy of Orthopedic Surgeons (AAOS), an appointed member of the task force to develop the AAOS Guidelines on Peri-prosthetic Infections of the Hip and Knee, and is

a member of the American Association of Hip and Knee Surgeons (AAHKS). Julie A. Kliger, MPA, BSN, RN, principal and CEO, The Altos Group Topic: Overcoming Resistance to Change Over the last 20 years Ms. Kliger has been very active as in the areas of health professional practice re-design, medical error reduction, improving sepsis care, systems’ improvement, quality improvement and provider professionalism. Currently Ms Kliger works with several organizations including University of California at San Francisco (UCSF) Medical Center, UCSF’s Center for Health Professions, Stanford University Hospital, San Francisco General Hospital, Kaiser Permenente Medical Centers, among others, directing a portfolio of $12M focused on addressing practice redesign in health care. T his work was nationally recognized for its unprecedented improvement results in medication administration re-design. In 2008 she founded the Regional Nurse Network, currently with over 3400 members. Ms. Kliger completed

her Masters in Public Administration at Harvard University’s Kennedy School of Government where she focused on patient safety and error reduction policies. She completed her Bachelor’s of Science in Nursing from Columbia University in New York City and her Bachelor’s of Arts from U.C Berkeley She has been an invited speaker at numerous national conferences including, Joint Commission, National Quality Forum, University Health Consortium (UHC), RAND Corp., Joint Commission, Stanford University, American College of Emergency Physicians (ACEP), BMJ’s International Conference. Ms. Kliger is a published author and her articles can be found in the Joint Commissions’ Journal on Quality and Patient Safety, Journal of Nursing Administration (March, 2010), Archives of Internal Medicine (April, 2010) among other notable publications. Jon C. Lloyd, MD, FACS, senior associate Positive Deviance Initiative, senior clinical advisor, Plexus Institute Topic: Unleashing Healthcare’s Secret

Change to Eliminate HAIs Dr. Lloyd is a senior associate at the Plexus Institute where he coaches several hospitals about applying Positive Deviance to the problems of youth violence and the twenty-five year disparity in longevity that affects people with serious mental illness. Dr. Lloyd completed training in general, thoracic and vascular surgery at the University of Pittsburgh Medical Center (UPMC) and was director of the Surgical Residency Program and the University Trauma Service. He served as Chairman, Department of Surgery, UPMC-Shadyside Hospital from 1978-1988. In July 2004, he became Pittsburgh Project Coordinator for the Centers for Disease Control and Prevention (CDC) and the Veterans Administration Pittsburgh Healthcare System to work on a community-wide effort to eliminate endemic Methicillin Resistant Staphylococcus aureus (MRSA). The MRSA prevention model that emerged out of this collaborative effort in Southwestern Pennsylvania resulted in grants from the Robert Wood

Johnson Foundation and the federal Agency for Health Research and Quality to support healthcare organizations in the U.S and Canada in using Positive Deviance (PD) as a cultural approach to fight healthcare acquired infections. Source: http://www.doksinet Rekha K. Murthy, MD, FRCP, director of Hospital Epidemiology, Division of Infectious Diseases, professor of Clinical Medicine at the University of California at Los Angeles (UCLA) Cedars-Sinai Medical Center Topic: The Role of the Environment in HAI: New Approaches for Decontamination and Monitoring Efficacy of Cleaning in the Healthcare Environment Dr. Murthy specializes in research that includes the prevention of hospital acquired infections, multidrug resistant organism control, as well as antimicrobial utilization. Dr. Murthy has served as chair of the Infection Control Committee and the Antibiotic Use Review Committee at Cedars-Sinai Medical Center, and co-chair of the Quality Council Multidrug Resistant Organism (MDRO)

Prevention Task Force, Cedars-Sinai Medical Center. She is a member of the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, and a Fellow of the American College of Physicians. Dr Murthy has been an invited lecturer on the topic of infectious diseases, as well as an author of book chapters, peer-reviewed research papers, and abstracts. She received her medical degree at Queen’s University School of Medicine, Kingston, Ontario, Canada and completed internship and residency programs in internal medicine at Queen’s University School of Medicine and Baylor College of Medicine, Houston, Texas. Dr Murthy performed clinical and research fellowships in infectious diseases at Brown University, Providence, Rhode Island, and the UCLA, San Fernando Valley Program. William A. Rutala, PhD, MPH, professor, Division of Infectious Diseases, Department of Medicine, University of North Carolina School of Medicine (Chapel Hill); director, Hospital

Epidemiology, Occupational Health, and Safety Program at UNC Health Care System; director, Statewide Program for Infection Control and Epidemiology Topic: How to Assess Risk of Disease Transmission When There Is a Failure to Follow Recommended Disinfection and Sterilization Principles Dr. Bill Rutala is a professor for the Division of Infectious Diseases at the University of North Carolinas School of Medicine, and serves as the director of Hospital Epidemiology, Occupational Health and Safety Program at the University of North Carolina Health Care System. He is also director and co-founder of the Statewide Program for Infection Control and Epidemiology at the UNC School of Medicine and a retired Colonel with the U.S Army Reserve Dr. Rutala is certified in infection control He is an advisor to the Centers for Disease Control and Prevention (a former member of the Healthcare Infection Control Practices Advisory Committee [HICPAC], 1999-2003), the Food and Drug Administration (a former

member of the General Hospital and Personal Use Devices Panel), the U.S Environmental Protection Agency (a member of the Scientific Advisory Panel on Antimicrobial Research Strategies for Disinfectants) and the Federal Trade Commission. He is a member of various committees on the local, state, national and international level as well as several professional societies including the American Society for Microbiology, Association for Professionals in Infection Control and Epidemiology and the Society of Healthcare Epidemiology of America. He serves on the editorial board of the Infection Control and Hospital Epidemiology Dr. Rutala has over 450 publications in the fields of infectious diseases, infection control, disinfection, sterilization and medical waste to include several guidelines (e.g, CDC Guideline for Disinfection and Sterilization in Healthcare Facilities). He has also been an invited lecturer at over 300 state, national Source: http://www.doksinet and international

conferences (in over 40 states and 25 countries) and has testified twice before the U.S Congress Dr. Rutala earned his Bachelor of Science degree in science from Rutgers University, his masters degree in microbiology from the University of Tennessee and both his masters in public health and doctorate in microbiology from the University of North Carolina School of Public Health. Rickson Sun, chief technologist, IDEO Topic: Behavioral Aspects of Hand Hygiene Compliance Mr. Sun collects new technologies to inspire project teams and translates technologies into storytelling tools for brands. His experience includes work in the areas of systems integration, IP Liberation, smart packaging, food packaging, medical devices and packaging, RFID tags, design for manufacturing, design-to-cost, value engineering, and project management. Rickson has developed home appliances, health and beauty products, diagnostic instrumentation for the healthcare industry, packaging for the personal computer

industry, seating and office panel systems and accessories for the contract furnishings industry. Some of his clients have been GE, Apple Computer, Procter and Gamble, Hewlett Packard, PepsiCo, Cargill, American Greetings, BMW, Kendall Jackson, Becton-Dickinson and Eli Lilly. More clients include Steelcase, Details, Origin, Inhale Therapeutics, Taurus Holdings, Motorola, Allsteel, Telenova, Next Computers, Sarns, 3M, CDI, Dupont, Samsonite, Pixar, General Magic, Taliq, Redwood Microsystems, Syva, Molecular Devices, Caliper, Applied ImmunoSciences, and Miles. Rickson holds over 20 patents. He holds BS and MS degrees in Mechanical Engineering and Product Design from Stanford University. Patricia A. Volkow Fernández, MD, Division of Infectious Diseases and Diagnostic and Therapeutic Resources, National Institute of Cancer, Mexico Topic: The “Universe” of Risks of Infusion Therapy Dr. Volkow is currently working in the Division of Infectious Diseases and Diagnostic and Therapeutic

Resources at the National Institute of Cancer in Mexico. She received her medical degree from the Universidad Nacional Autónoma de México in 1982 and completed postgraduate studies in Internal Medicine in 1985 and Infectious Diseases in 1987 at the Instituto Nacional de la Nutrición “Salvador Zubirán” Postgraduate Division, Faculty of Medicine. Dr Volkow has authored numerous publications in the area of infectious disease and HIV/AIDS and has held positions as an Infectious Disease Professor, National Researcher and Infectious Diseases Department Head. David Warren, M.D, MPH, epidemiologist, Barnes-Jewish Hospital Topic: The Changing Environment of Infection Prevention Since 2004, Dr. Warren has served as the Hospital Epidemiologist for Barnes-Jewish Hospital His research centers around the epidemiology and prevention of healthcare associated infections, understanding risk factors for colonization and infection with antimicrobial-resistant bacteria among hospitalized patients,

particularly methicillin-resistant S. aureus (MRSA), and developing methods of preventing the continuing spread of these organisms within healthcare and the community. He is involved in a study of the effectiveness of use of a daily chlorhexidine skin preparation in reducing healthcare-associated infections. He is also interested in determining prognostic indicators for bloodstream infections among hospitalized patients, with special emphasis on catheter-associated infections and Staphylococcus aureus. Dr Warren is currently funded by the CDC, AHRQ and the BJH Foundation. Source: http://www.doksinet He received his M.D from the University of Pittsburgh and Masters in Public Health from St Louis University. He completed his internal medicine training and fellowship in infectious diseases at Washington University School of Medicine before joining the faculty in the Infectious Diseases Division in 2001. ###